Please login to the form below

COUCH Health Engages Mark Duman as Chief Strategy Officer

MANCHESTER, United Kingdom, June 15, 2021— COUCH Health, a patient engagement agency, announced the appointment of Mark Duman as its Chief Strategy Officer (CSO).

Taking charge of strategy development and execution for COUCH Health, Mark will oversee the expansion of COUCH Health’s mission to contribute to inclusive clinical trials that prioritise the patient experience. Mark will report directly to CEO Ash Rishi.

“It has been exciting to watch COUCH Health mature in recent years and firmly establish itself in the industry. I’ve always been impressed by its resolute focus to put patients front and centre in life sciences R&D,” said Mark. “I’m truly delighted to join the team and use my experience to help drive future growth”.

A pharmacist by training, with a proven track record in helping organisations realise the full potential of their products and services, Mark Duman has over 30 years’ worth of experience working in the healthcare sector for clients including AstraZeneca, Department of Health, JnJ, Microsoft, NHS England, Novartis, Roche Diagnostics, Royal College of Surgeons, Siemens Healthineers and Tunstall Group.

COUCH Health CEO Ash Rishi added: “We’re thrilled to welcome Mark to COUCH Health. I’ve always been inspired by his energy and enthusiasm for everything that he works on. His Patient First attitude is a great match for COUCH Health and that, along with his wealth of experience and expertise in our industry, will be instrumental in maximising COUCH Health’s capacity to grow and serve new clients.”

COUCH Health works globally with pharma, biopharma, medical device companies and CROs, providing insights, patient recruitment, patient retention, and investigator site support.

To learn more about COUCH Health, visit:

COUCH Health makes clinical trials more human. We are a patient engagement agency that prioritises diversity, inclusion, and patient experiences during clinical trials. Through our work with pharma, biopharma, medical device companies and CROs, COUCH Health delivers a patient-first approach through patient insights, patient recruitment, patient retention, and investigator site support. Learn how we improve clinical trial experiences at

For further information, please contact Josie Stein at

21st June 2021



Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Suite 2.10, Jactin House
24 Hood Street
M4 6WX
United Kingdom

Latest content on this profile

#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need unconscious bias training.”
COUCH Health
How do ethnic minority groups in the U.S. view clinical trials?
This year, we decided to do the same with ethnic minority communities over in the United States (U.S.) too. Ultimately, we wanted to explore attitudes towards clinical trials from these communities, understand the barriers in participation, and determine what factors may influence people’s decisions to take part.
COUCH Health
Three things to consider when using social listening research for patient recruitment
We are looking at how patient research can power your patient recruitment campaign. A look into social listening follows on from this blog perfectly, offering a stronger and more authentic alternative to relying on data trends to guide your activities. So, let’s get started…
COUCH Health
4 ways mobile ethnography studies can elevate your patient insights
How can we achieve more real-life, in-the-moment insights from different groups to understand their thoughts and behaviours? This is where ethnography studies come in.
COUCH Health
#DemandDiversity: We’re calling on the clinical trials industry to include us all
The lack of diversity in clinical trials is something we’ve spoken about time and time again. By now, you might think we sound a bit like a broken record. But, the fact is, many people still aren’t aware of the underrepresentation, especially those who don’t work in the industry. Do you think if the clinical research industry could see the people they were leaving out of clinical trials, and hear how they felt about being underrepresented, it would make a difference?
COUCH Health
Include Us All in Your Clinical Trials

COUCH Health